| Steve J. Kubisen, Ph.D. | President and Chief Executive Oficer |
 |
Steve has over 20 years experience in senior management positions in the materials and manufacturing industries serving the health care, industrial and electronics markets. Over the last 7 years, he has commercialized early stage technologies from leading universities in a variety of medical device, materials, electronics, and manufacturing businesses, with a principle focus on start-up formation.
Most recently, Steve was Senior Director of Ventures at Johns Hopkins University, where, during his 3 year tenure, the institution increased start-ups, from a historical annual level of 4, to 12 in 2008, with $76M raised, and 10 in 2009. As Vice President of Technology Commercialization at Utah State University Research Foundation, he tripled licensing revenue and moved the institution into the top five in the nation for start-ups per research dollar. As President of VEC Technology, an early stage composites molding company, Steve significantly improved operations and revenues, yielding a 10 X valuation increase ($110M) on exit. Steve spent 8 years with GE, where as General Manager of GE Electromaterials he commercialized a revolutionary circuit board material for the emerging computer and telecommunications industries and as General Manager of Global RD&E of the $500M GE Silicones Division instituted systems to double new product sales.
Prior to GE, Steve held various senior management positions with Akzo Nobel and Union Carbide Corporation. Steve has an A.B. in chemistry from Cornell University and a Ph.D. in organic chemistry from Harvard University.
|
| |
| BACK TO TOP >> |
| |
| Tony P. Deasey | Chief Financial Officer |
 |
Over the last 20 years Mr. Deasey has served as Chief Financial Officer of five companies including three public and two privately held companies. Since starting his career in public accounting with Price Waterhouse in London, England, Tony has built a broad global financial and operational experience base across several industries.
Most recently, Tony served as Chief Financial Officer of Northwest Biotherapeutics, Inc. a biotech company focused on the development of personal dendritic cell based vaccines to treat a variety of cancer indications. Prior to Northwest Biotherapeutics, Tony served as Chief Financial and Chief Operating Officer of Celsion Corporation where he led the transformation of the company from a medical device company to a fully fledged drug development company in late stage trials to treat primary liver cancer.
Before joining Celsion Tony had been Chief Financial Officer of World Kitchen Inc., Rollerblade Inc. and Church & Dwight Co. Inc. and had served in increasingly senior positions in Chesebrough Ponds and Unilever.
|
| |
| BACK TO TOP >> |
| |
| Dennis Smith | Vice President of Engineering |
 |
As an independent medical device design and program management consultant, Mr. Smith has worked with Mayo Clinic, Medifocus and Sensors for Medicine and Science providing services in Product Design, Manufacturing, Quality Systems and Regulatory Compliance. From 2000 to 2007, Mr. Smith worked as Vice President, Engineering for Celsion Corporation, completing the successful design, commercial launch, and sale to Boston Scientific of Prolieve a Class III Medical Device for the treatment of Benign Prostatic Hyperplasia and developing cancer treatment medical devices. From 1985 to 1995, Mr. Smith served as Director of Engineering of Cheung Laboratories. From 1995 to 2000, Mr. Smith was Director Engineering for Talla-Com Industries Inc, a division of Tadiran Electronics (Israel), manufacturing and designing high power RF amplifiers for the US Military Communications marketplace. Mr. Smith was educated in the United Kingdom at the University of Manchester Institute of Technology and the Reading College of Technology.
|
| |
| BACK TO TOP >> |
| |
| |